Contract 75A50126C00010
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†
† DoD contract data posts to USAspending about 90 days after award.
A single federal award, with both ends of the trail linked.
Award 75A50126C00010 is a contract from the Department of Health and Human Services, $96.1M obligated, FY2026 to FY2035. The work is performed in Virginia. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN11 (Health R&D Services; Health Care Services; Basic Research). Source
Description
This Acquisition Will Allow BARDA to Invest Project Bioshield Funds for Late-Stage Clinical Development, Regulatory Approval for 2-PAM Autoinjectors (as a Drug/Device Combination Product) to Treat Organophosphate (Op) Poisoning, Including Nerve Agent